GE HealthCare slides as Citi trims price target, analysts remain split
GE HealthCare (GEHC) fell about 3% as investors reacted to a fresh analyst reset that trimmed expectations for the stock. Citigroup cut its price target to $84 from $88 while keeping a Neutral rating, adding to recent mixed Wall Street positioning on the name.
1) What’s moving the stock
GE HealthCare shares are trading lower in a risk-off move that appears tied to the latest wave of analyst recalibration on the stock. The most concrete catalyst in recent news flow is Citigroup’s March 11, 2026 note lowering its GEHC price target to $84 from $88 while maintaining a Neutral rating, which has reinforced the “good company, but valuation/near-term setup” push-pull that has been hanging over the name in 2026. (gurufocus.com)
2) Analyst backdrop: upgrades, downgrades, and a widening spread
GEHC’s tape has been sensitive to analyst dispersion—bulls continue to point to product cycle and longer-run execution, while bears highlight valuation and macro/market headwinds. Recent examples underscore that split: Stifel recently reiterated a Buy rating with a $98 target following physician discussions around Flyrcado, while UBS previously downgraded GEHC to Sell with a $77 target. (in.investing.com)
3) Price action and what traders are seeing
GEHC is trading around $69, after opening near $71 and sliding to roughly $69 at the session low, with the decline consistent with the stock’s recent pattern of sharp, sentiment-driven pullbacks around incremental analyst headlines. With GEHC sitting well below its recent moving averages cited in market commentary, momentum-oriented accounts may be treating bounces as opportunities to reduce exposure until a clearer fundamental catalyst emerges. (ad-hoc-news.de)